Andrographis 图表
46 来自同行评审研究的图表
Inflammatory cytokine levels in lung tissue were measured following radiation exposure and andrographolide treatment. The data suggest that andrographolide suppresses pro-inflammatory mediator release in irradiated lung tissue.
Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced …
AIM2 inflammasome activation and caspase-1-mediated pyroptosis play key roles in radiation-induced lung inflammation. This figure presents protein expression data showing andrographolide's inhibitory effects on the AIM2 inflammasome pathway.
Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced …
Gasdermin D cleavage is a downstream event in pyroptotic cell death triggered by radiation. Western blot analysis demonstrates that andrographolide reduces Gasdermin D processing in macrophages exposed to radiation.
Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced …
Immunofluorescence or protein analysis reveals that andrographolide prevents AIM2 from binding cytoplasmic DNA and forming active inflammasome complexes. These findings indicate a specific molecular target for andrographolide's protective mechanism.
Inhibition of AIM2 inflammasome-mediated pyroptosis by Andrographolide contributes to amelioration of radiation-induced …
Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Experimental results examining early intervention with Kan Jang® to treat upper, with data points illustrating key findings related to BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Statistical analysis from research investigating early intervention with Kan Jang® to treat upper, comparing treatment groups and control conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Measured parameters from a study evaluating early intervention with Kan Jang® to treat upper, contributing to the overall assessment of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Graphical representation of outcomes in a study of early intervention with Kan Jang® to treat upper, highlighting trends observed across experimental conditions.
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
Quantitative data from a study on early intervention with Kan Jang® to treat upper, presenting measured outcomes relevant to the investigation of BACKGROUND AND AIM: Andrographis paniculata and Eleutherococcus senticosus preparations and their fixed combination, .
Early intervention with Kan Jang® to treat upper-respiratory tract infections: A randomized, …
第 1 页，共 2 页